No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

geko Device Makes its Debut

Presented at the Orthopaedic Summit 2019: Evolving Techniques (OSET 2019) Annual Meeting in Las Vegas

Editor: What To Know

  • Through an innovative mechanism of bioelectronic neuromuscular electrostimulation, the daily disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf for the prevention and treatment of pre and post-operative edema and the prevention of venous thromboembolism (VTE) –.
  • Jason Snibbe, MD, a fellow from the Kerlan-Jobe Institute, USC team surgeon, and an orthopedic surgeon practicing in Los Angeles, CA presented a real-world total knee replacement (TKR) patient case study to an audience of over 900 orthopedic surgeons and healthcare professionals.
  • Snibbe presented the clinical rationale and his use of the FDA cleared the geko™ device to prevent the build-up of edema on the lower extremity orthopedic procedures he performs.

geko Device: Jason Snibbe, MD, a fellow from the Kerlan-Jobe Institute, USC team surgeon, and an orthopedic surgeon practicing in Los Angeles, CA presented a real-world total knee replacement (TKR) patient case study to an audience of over 900 orthopedic surgeons and healthcare professionals.

The case focused on the patient’s range of motion and mobility issues following total knee arthroplasty, where edema was determined as the culprit.

Dr. Snibbe presented the clinical rationale and his use of the FDA cleared the geko™ device to prevent the build-up of edema on the lower extremity orthopedic procedures he performs.  Dr. Snibbe later presented in a corporate-sponsored symposium further information titled, Post-Operative Edema in Orthopaedics-Clinical Implications and an Innovative Solution along with Dr. Brian Loyd from the University of Utah.

Post-operative edema occurs in over 90% of total hip and knee replacement patients1,2 and is one of the main post-operative challenges where there is no dependable solution. Attendees heard from faculty thought-leaders on the economic burden edema creates, as well as detail on this new, disruptive technology that provides a long-needed solution for the orthopedic community – the geko™ device – a wearable, edema management therapy.

The geko™ device is the size of a wristwatch and worn at the knee. Through an innovative mechanism of bioelectronic neuromuscular electrostimulation, the daily disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf for the prevention and treatment of pre and post-operative edema and the prevention of venous thromboembolism (VTE) – in both surgical and medical patients at risk of VTE.

Evidence presented also demonstrated that swelling complications are experienced beyond 50 days, continuing in many patients for over 3 months2, as well as RCT data demonstrating geko™ device prevention of post-operative edema build-up in total hip replacement patients3.

Practicing in the Los Angeles area, Dr. Jason Snibbe, is a board-certified orthopedic surgeon, with fellowship training in Sports Medicine and Joint Replacement Surgery. He performs surgery on the shoulder, elbow, hip, and knee. His practice has a special focus on hip preservation and reconstructive surgery. He specializes in hip preservation techniques using advanced arthroscopic hip surgery. He also performs minimally invasive hip and knee replacements which allow patients an accelerated recovery.

Dr Brian J Loyd, University of Utah, department of physical therapy, began his clinical research career, completing a Doctor of Physical Therapy degree at Texas Tech University Health Sciences Center. After earning his DPT, Loyd began his Ph.D. program in rehabilitation science at the University of Colorado Anschultz Medical Campus with a focus on improving function and recovery in mobility-limited populations. During his Ph.D. training, Loyd was a contributing or first author on 7 peer-reviewed publications and the first author on 9 peer-reviewed conference abstracts. He completed this work under the mentorship of Jennifer Stevens-Lapsley, PT, Ph.D.


References:

1. K.L. Kluga et al Improving Orthopedic-Related Postoperative Edema Management in a Rehabilitative Nursing Setting. Rehabilitation Nursing, 44(3), 151–160. doi: 10.1097/rnj.0000000000000104.

2. B. J. Loyd et al. Development of a reference chart to monitor postoperative swelling following total knee arthroplasty. Disability and Rehabilitation, DOI: 10.1080/09638288.2018.1534005.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy